Viral Immunology, Vaccines, and Antivirals
A section of Viruses (ISSN 1999-4915).
Section Information
- acquired resistance and evolution
- regulatory/societal/legislation aspects
- immune system stimulation
- limitations of vaccines
- new developments and the future
- natural antivirals and their uses
- viral infections
- differences between antivirals and antibiotics in health care
- antiviral use in children
- immunology/animal models
- adverse effects
Editorial Board
Topical Advisory Panel
Click here to see the Section Topical Advisory Panel of "Viral Immunology, Vaccines, and Antivirals".
Special Issues
Following special issues within this section are currently open for submissions:
- Influenza, SARS-CoV-2, RSV and Other Vaccines: Immunogenicity Parameters and Protection, 3rd Edition (Deadline: 30 May 2025)
- RNA Viruses Replication and Innate Immunity (Deadline: 31 May 2025)
- Pharmacology of HIV Treatment and Antivirals Against Hepatitis Viruses (Deadline: 31 May 2025)
- Role of Lectins in Viral Infections and Antiviral Intervention (Deadline: 31 May 2025)
- Chronic Infection by Oncogenic Viruses (Deadline: 31 May 2025)
- Viral Sepsis: Pathogenesis, Diagnostics and Therapeutics (Deadline: 30 June 2025)
- HIV Protease (Deadline: 30 June 2025)
- Interferon Signaling in Viral Pathogenesis (Deadline: 30 June 2025)
- Advances in Small-Molecule Viral Inhibitors (Deadline: 15 July 2025)
- Unraveling the Pathogenesis of Persistent Virus Infection (Deadline: 15 July 2025)
- Virus-Host Protein Interactions (Deadline: 31 July 2025)
- Viral Resistance (Deadline: 31 July 2025)
- Swine Viruses: Immunology and Vaccinology (Deadline: 15 August 2025)
- Broadly Protective Anti-Viral Vaccines 2025 (Deadline: 29 August 2025)
- Antiviral Resistance Mutations (Deadline: 31 August 2025)
- Emerging and Re-Emerging Zoonotic Viruses: Current Challenges in Vaccinology (Deadline: 31 August 2025)
- Roles of Macrophages in Viral Infections, 2nd Edition (Deadline: 31 August 2025)
- Natural, Semisynthetic, and Synthetic Antiviral Drugs Targeting HIV and SARS-CoV-2 (Deadline: 31 August 2025)
- Antiviral Agents to Influenza Virus 2025 (Deadline: 31 August 2025)
- Host Cell-Virus Interaction, 4th Edition (Deadline: 30 September 2025)
- Therapeutic Interfering Particles (TIPs): A Promising Treatment for Viral Infections (Deadline: 30 September 2025)
- Viral Strategies to Regulate Host Immunity or Signal Pathways 2nd Edition (Deadline: 30 September 2025)
- Development of Diagnostics and Therapeutic Interventions for Viral Infections of the Central Nervous System (Deadline: 30 September 2025)
- Human Leukocyte Antigen (HLA) in Viral Infections (Deadline: 30 September 2025)
- Recent Advances in Anti-HCV, Anti-HBV and Anti-Flavivirus Agents, 2nd Edition (Deadline: 30 September 2025)
- Recent Advances in Antiviral Natural Products 2025 (Deadline: 30 September 2025)
- Mechanisms of Herpesvirus Resistance (Deadline: 30 September 2025)
- Conquering Antiviral Drug Resistance via Development of Novel Antivirals and New Testing Methods for Drug Resistance: From Bench to Bedside (Deadline: 15 October 2025)
- Virus Infections and Host Metabolism 2025 (Deadline: 31 October 2025)
- Innate and Adaptive Immune Responses to Arbovirus Infections (Deadline: 31 October 2025)
- 2nd Edition: How to Adjust the Action Steps for Achieving the Global Hepatitis Virus (HBV/HCV/HDV) Elimination Targets? (Deadline: 31 October 2025)
- Vaccines and Antiviral Drugs Against Viral Diseases in Domestic Animals (Deadline: 31 October 2025)
- Host-Directed Antiviral Therapy (Deadline: 15 November 2025)
- Structure-Based Antiviral Drugs and Vaccine Design (Deadline: 15 December 2025)
- Immune Mechanisms Against Respiratory Viral Pathogens (Deadline: 30 December 2025)
- Antiviral Development for Emerging and Re-Emerging Viruses (Deadline: 31 December 2025)
- Interferon-Stimulated Genes in Antiviral Immunity (Deadline: 31 December 2025)
- Virology and Immunology of Gene Therapy 2025 (Deadline: 31 December 2025)
- Picornavirus Evolution, Host Adaptation and Antiviral Strategies (Deadline: 31 December 2025)
- Lung Immunity to Viral Infections (Deadline: 31 December 2025)
- Host Defense, Viruses and Cell Death Pathways (Deadline: 31 January 2026)
- Pharmacology of Antiviral Drugs, 2nd Edition (Deadline: 28 February 2026)
- Humoral Immune Response to Viruses (Deadline: 6 June 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
